Prolymphocytic Leukemia

Prolymphocytic Leukemia is a rare and aggressive form of leukemia characterized by the clonal proliferation of prolymphocytes, predominantly of B-cell or T-cell lineage, distinguished from other leukemias by the predominance of mature-appearing yet immunophenotypically aberrant prolymphocytes in the peripheral blood and bone marrow.

419

Publications

22K

Citations

2.1K

Authors

659

Institutions

Publications per year

2017–2026

32

Variants

Prolymphocytic Leukaemia

Authors

2.1K

  1. DC
    Daniel Catovsky

    Institute of Cancer Research, United Kingdom

    57 publications · 5K citations

    35

    h-index

  2. EM
    Estella Matutes

    Royal Marsden Hospital, United Kingdom

    23 publications · 1.8K citations

    21

    h-index

  3. MJ
    Michael J. Keating

    The University of Texas MD Anderson Cancer Center, United States

    14 publications · 1.1K citations

    14

    h-index

  4. EM
    E Matutes

    Royal Marsden Hospital, United Kingdom

    15 publications · 1.1K citations

    14

    h-index

  5. RM
    Ricardo Morilla

    Royal Marsden Hospital, United Kingdom

    11 publications · 879 citations

    11

    h-index

1–5 of 2.1K

Venues

  1. British Journal of Haematology

    BJH · 40 publications · 3.3K citations

    30

    h-index

  2. Blood

    28 publications · 2.8K citations

    24

    h-index

  3. PubMed

    Repository · 46 publications · 1.7K citations

    24

    h-index

  4. American Journal of Clinical Pathology

    AJCP · 25 publications · 975 citations

    19

    h-index

  5. Leukemia & lymphoma/Leukemia and lymphoma

    30 publications · 880 citations

    19

    h-index

1–5